HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[HLA-DR2 alleles and uveitis in leprosy].

Abstract
In order to investigate the role of immunogenetic factors in the pathogenesis of uveitis in leprosy, HLA antigens were analyzed between the leprotics with and without uveitis. Sixty-five Japanese leprosy patients comprised 32 with uveitis and 33 without uveitis. Controls consisted of 138 healthy subjects. A lymphocyte cytotoxicity test was used for typing HLA-A, -B, -C, -DR and -DQ antigens. HLA-DR2 genotyping was performed by the polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) and PCR-restriction fragment length polymorphism (RFLP) methods. The frequency of HLA-DR2 antigen was significantly increased in the patients with uveitis as compared with the control subjects (Pc < 0.0005), whereas HLA-DR53 antigen was significantly decreased (Pc < 0.05). At the genomic level the frequency of HLA-DRB1*1501 was significantly increased in the patients with uveitis and without uveitis as compared with that in the controls. The association with DRB1*1501 was even stronger in patients with uveitis (odds ratio = 7.1, Pc < 0.000005) than in the patients without uveitis (odds ratio = 4.1, Pc < 0.005). Our results suggest that HLA-DRB1*1501 contribute to the susceptibility to uveitis in the Japanese with leprosy.
AuthorsS Joko, J Numaga, Y Fujino, K Masuda, R Hirata, H Maeda
JournalNihon Rai Gakkai zasshi (Nihon Rai Gakkai Zasshi) Vol. 64 Issue 2 Pg. 112-8 (Jul 1995) ISSN: 0386-3980 [Print] Japan
PMID7592159 (Publication Type: English Abstract, Journal Article)
Chemical References
  • HLA-DR2 Antigen
Topics
  • Alleles
  • Disease Susceptibility (immunology)
  • Genetic Predisposition to Disease
  • HLA-DR2 Antigen (genetics)
  • Humans
  • Leprosy (genetics, immunology)
  • Uveitis (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: